human relevance remains uncertain, warranting informed discussion and baseline screening when appropriate
Save challenging social meals for when levels are moderate
This could include: Heart rate assessment at 4-8 weeks after initiation or dose escalation Periodic electrocardiography if arrhythmias are suspected Patient self-monitoring of pulse if symptomatic palpitations occur Evaluation of heart rate control in patients with atrial fibrillation When evaluating tachycardia in patients on GLP-1 therapy, clinicians should assess for other potential causes, including dehydration (especially from GI side effects), anemia, hyperthyroidism, stimulant use, infection, or other medications
Diary data showed a higher proportion of nopain days (89% vs 85%), and mean phototoxic reactions per patient were lower (2.03.3 vs 3.36.8)
Oral glutathione supplements are increasingly popular and topical regimens and other options are also available
-Glu-C16, -L-glutamoyl(N -hexadecanoyl)